Search Results - "Kranwinkel, Grace"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study by Rincon, Fred, Sacco, Ralph L, Kranwinkel, Grace, Xu, Qiu, Paik, Myungee C, Boden-Albala, Bernadette, Elkind, Mitchell S V

    “…To assess the prevalence of risk factors as determinants of intracranial atherosclerosis (IATH)-related stroke in a multi-ethnic community-based cohort. The…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors by Hershman, Dawn L., Greenlee, Heather, Awad, Danielle, Kalinsky, Kevin, Maurer, Matthew, Kranwinkel, Grace, Brafman, Lois, Jayasena, Ramona, Tsai, Wei-Yann, Neugut, Alfred I., Crew, Katherine D.

    Published in Breast cancer research and treatment (01-04-2013)
    “…In 2006, the IOM released a report citing the importance of “survivorship plans” to improve quality of life and care coordination for cancer survivors, but…”
    Get full text
    Journal Article
  4. 4

    Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume The Northern Manhattan Study (NOMAS) by KHATRI, Minesh, WRIGHT, Clinton B, NICKOLAS, Thomas L, YOSHITA, Mitsuhiro, PAIK, Myunghee C, KRANWINKEL, Grace, SACCO, Ralph L, DECARLI, Charles

    Published in Stroke (1970) (01-12-2007)
    “…White matter hyperintensities have been associated with increased risk of stroke, cognitive decline, and dementia. Chronic kidney disease is a risk factor for…”
    Get full text
    Journal Article
  5. 5

    Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer by Greenlee, Heather, Crew, Katherine D., Shao, Theresa, Kranwinkel, Grace, Kalinsky, Kevin, Maurer, Matthew, Brafman, Lois, Insel, Beverly, Tsai, Wei Yann, Hershman, Dawn L

    Published in Supportive care in cancer (01-04-2013)
    “…Purpose Many women with hormone receptor-positive breast cancer discontinue effective aromatase inhibitor (AI) treatment due to joint symptoms. Methods We…”
    Get full text
    Journal Article
  6. 6
  7. 7